First report of Enterobacter hormaechei with respiratory disease in calves [PDF]
BMC Veterinary Research, 2020 Background Enterobacter hormaechei is commonly considered a causative pathogen for nosocomial infections and it does not usually cause diseases in animals.
Zhicheng Wang +7 more
doaj +5 more sources
Enterobacter hormaechei subsp. hoffmannii subsp. nov., Enterobacter hormaechei subsp. xiangfangensis comb. nov., Enterobacter roggenkampii sp. nov., and Enterobacter muelleri is a later heterotypic synonym of Enterobacter asburiae based on computational analysis of sequenced Enterobacter genomes. [version 2; referees: 2 approved] [PDF]
F1000Research, 2018 Background: The predominant species in clinical Enterobacter isolates is E. hormaechei. Many articles, clinicians, and GenBank submissions misname these strains as E. cloacae. The lack of sequenced type strains or named species/subspecies for some clades
Granger G. Sutton +3 more
doaj +5 more sources
Whole-Genome Sequence and Fermentation Characteristics of Enterobacter hormaechei UW0SKVC1: A Promising Candidate for Detoxification of Lignocellulosic Biomass Hydrolysates and Production of Value-Added Chemicals [PDF]
Bioengineering, 2023 Enterobacter hormaechei is part of the Enterobacter cloacae complex (ECC), which is widespread in nature. It is a facultative Gram-negative bacterium of medical and industrial importance.
Santosh Kumar +2 more
doaj +4 more sources
Molecular detection of Enterobacter hormaechei in bovine respiratory disease [PDF]
Veterinární MedicínaBovine respiratory disease (BRD) develops from complex interactions among environmental, host and pathogenic factors. This study aimed to phenotypically identify Enterobacter hormaechei isolated from cattle with BRD and assess antimicrobial ...
HAJ Gharban
doaj +4 more sources
Carbapenem-resistant Enterobacter hormaechei uses mucus metabolism to facilitate gastrointestinal colonization [PDF]
mBioThe emergence and global spread of carbapenem-resistant Enterobacter cloacae complex species present a pressing public health challenge. Carbapenem-resistant Enterobacter spp.
Ritam Sinha +4 more
doaj +5 more sources
Emergence and transmission of the high-risk ST78 clone of OXA-48-producing Enterobacter hormaechei in a single hospital in Taiwan [PDF]
Emerging Microbes and InfectionsCarbapenem-resistant Enterobacter cloacae complex is a significant global healthcare threat, particularly carbapenemase-producing Enterobacter hormaechei (CPEH).
Chih-Ming Chen +2 more
exaly +4 more sources
Case report of enterobacter hormaechei in sheep with respiratory disease and death [PDF]
BMC Veterinary Research, 2022 Background Enterobacter hormaechei is typically a opportunistic pathogenic bacterium in humans, and no pathological change of of Enterobacter hormaechei in diseased sheep has previously been documented.
Hongfei Shi +5 more
doaj +7 more sources
Microbiology Spectrum, 2022 Multidrug resistance (MDR) in Enterobacteriaceae including resistance to quinolones is rising worldwide. The plasmid-mediated quinolone resistance (PMQR) gene qnrS is prevalent in Enterobacteriaceae. However, the qnrS gene is rarely found in Enterobacter
Kaixuan Guo, Xiangru Wang, Zhong Peng
exaly +3 more sources
Enterobacter hormaechei as a Growth-Promoting Bacterium and Its Involvement in the Control of Sugarcane Smut [PDF]
Arab Universities Journal of Agricultural SciencesThis study examined bacterial isolates from the inner stalk tissues of 50 sugarcane samples collected from Aswan Governorate, Egypt. Of the isolates, 10 showed varying degrees of inhibition against Sporisorium scitamineum in vitro. The highest inhibition
Ayman Esh, Shadia Taghian
doaj +2 more sources
Endophytic Bacteria Enterobacter hormaechei Fabricated Silver Nanoparticles and Their Antimicrobial Activity [PDF]
Pharmaceutics, 2021 Antimicrobial resistance (AMR), one of the greatest issues for humankind, draws special attention to the scientists formulating new drugs to prevent it. Great emphasis on the biological synthesis of silver nanoparticles (AgNPs) for utilization in single or combinatorial therapy will open up new avenues to the discovery of new antimicrobial drugs.
Tahmina Monowar +2 more
exaly +4 more sources